GDNF and Parkinson disease: Miglior’s study demonstrated that the intranasal administration of Glial cell line-derived neurotrophic factor (GDNF) plasmid to the brain regions of PD models resulted in neurotrophic and neuroprotective effects in PD rat models (Migliore et al., 2014).